Efficacy, Safety and Quality of Life of Palifermin on Reducing Oral Mucositis in Patients With Hematopoietic Stem Cell Transplantation, Prospective Double-blind Randomized Phase III Trial
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Palifermin (Primary)
- Indications Mucositis
- Focus Therapeutic Use
Most Recent Events
- 16 Dec 2014 New trial record